Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Suda

Showing results (571-580 of 834) with videos related to

Pageof 84
Sort By:
Endocrinology|August 1, 1996
Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contactE Jimi, I Nakamura, H Amano, et al.
Endocrinology|June 1, 1996
Major role of 3',5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivoK Itoi, N Horiba, F Tozawa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1989
Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell culturesT Akatsu, N Takahashi, K Debari, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1987
Radioimmunoassay of corticotropin-releasing hormone: methodology and clinical applicationT Suda, N Tomori, T Sumitomo, et al.
The Journal of Biological Chemistry|September 25, 1987
Isolation, identification, and chemical synthesis of 8 alpha,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one. A new metabolite of 25-hydroxyvitamin D3 produced by mouse myeloid leukemia cells (M1)S Yamada, K Yamamoto, H Takayama, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
A short negative feedback mechanism regulating corticotropin-releasing hormone releaseT Suda, N Tomori, F Yajima, et al.
Journal of Cellular Physiology|September 10, 1998
Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of timeT Tsurukai, N Takahashi, E Jimi, et al.
FEBS Letters|June 29, 1987
Phagocytic cells metabolize 25-hydroxyvitamin D3 to 10-oxo-19-nor-25-hydroxyvitamin D3 and a new metabolite, 8 alpha,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-oneT Hayashi, S Yamada, C Miyaura, et al.
Endocrinologia Japonica|December 1, 1988
The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's diseaseE Odagiri, R Demura, H Demura, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3E Abe, C Miyaura, H Sakagami, et al.
Pageof 84

Showing results (571-580 of 834) with videos related to

Sort By:
Pageof 84
Endocrinology|August 1, 1996
Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contactE Jimi, I Nakamura, H Amano, et al.
Endocrinology|June 1, 1996
Major role of 3',5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivoK Itoi, N Horiba, F Tozawa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1989
Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell culturesT Akatsu, N Takahashi, K Debari, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1987
Radioimmunoassay of corticotropin-releasing hormone: methodology and clinical applicationT Suda, N Tomori, T Sumitomo, et al.
The Journal of Biological Chemistry|September 25, 1987
Isolation, identification, and chemical synthesis of 8 alpha,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one. A new metabolite of 25-hydroxyvitamin D3 produced by mouse myeloid leukemia cells (M1)S Yamada, K Yamamoto, H Takayama, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
A short negative feedback mechanism regulating corticotropin-releasing hormone releaseT Suda, N Tomori, F Yajima, et al.
Journal of Cellular Physiology|September 10, 1998
Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of timeT Tsurukai, N Takahashi, E Jimi, et al.
FEBS Letters|June 29, 1987
Phagocytic cells metabolize 25-hydroxyvitamin D3 to 10-oxo-19-nor-25-hydroxyvitamin D3 and a new metabolite, 8 alpha,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-oneT Hayashi, S Yamada, C Miyaura, et al.
Endocrinologia Japonica|December 1, 1988
The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's diseaseE Odagiri, R Demura, H Demura, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3E Abe, C Miyaura, H Sakagami, et al.
Pageof 84